Memoirs

  • October 03

    Molecule to Market Memoirs: Adam Sherlock

    Forty years. Six exits. And still not ready to hang up the boots. When I sat down with Adam Sherlock, CEO at Qinecsa, I came away with three big lessons: What I liked about Adam: he’s a genuinely lovely guy — friendly, kind, generous, and wonderfully understated considering his track record. What I admire most is …

  • September 26

    Molecule to Market Memoirs: Matt Lowe

    The challenger changing how pharma thinks about digital Matt Lowe is a force of nature. After two decades in the pharmaceutical world, he spotted a glaring blind spot in how the industry approaches search, customer experience and digital marketing. So he left big pharma, built Performance.io from the ground up, and set out to challenge …

  • August 29

    Molecule to Market Memoirs: Dr Stephen Dilly

    Doc to CEO – 40 years of reinvention in biopharma Every now and then you meet someone whose career just blows you away — not just for what they’ve achieved, but for how grounded they are about it. Dr Stephen Dilly has spent almost 40 years in the biopharma industry and 20 of those as …

  • August 08

    Molecule to Market Memoirs: Andrea Wagner

    The rain-making, 2X exit founder Dr Andrea Wagner’s story is a masterclass in grit, reinvention and unapologetic entrepreneurship. She’s built not one but two successful sterile manufacturing companies from scratch, both to exit. And now she’s back at it again, tackling engineering downtime with her new venture, PharmaPhixx. When I sat down with Andrea, I …

  • August 01

    Molecule to Market Memoirs: Ankit Gupta

    The Indian CEO driving change Ankit Gupta’s journey into pharma was completely accidental — but his rise since then has been anything but. From falling into the sector during the 2008 financial crisis to now leading InstaPill Private Limited (Formerly Tenshi Kaizen Private Limited), one of India’s most exciting pharma technology companies, his story is …

  • April 01

    Step Inside the Future of Biologics at Festival of Biologics USA 2025

    At Molecule to Market, we’re always spotlighting the game changers in pharma and biotech. That’s exactly why we’re proud to be a partner and sponsor of Festival of Biologics USA 2025, hosted by Terrapinn. This event isn’t just another date on the industry calendar. It’s where biologics leaders, innovators, and disruptors come together to shape …

  • December 19

    Molecule to Market: 2024 Wrapped

    A lookback at 2024 and how the pharma services space was shaped by market headwinds, GLP-1, rising stars and green shoots.

  • August 28

    Molecule to Market & ramarketing CPHI panel discussion event – register to attend!

    From strategy to success: Crafting your commercial growth blueprint CPHI Milan – Wednesday, October 9th – Fiera Milano LEM 1, Room A – 4:30pm onward Tired of the same old, same old at CPHI? Ready for actionable insights tailored to life science marketers to supercharge your growth strategy? Join us at CPHI Worldwide in Milan …

  • July 23

    Pharma outsourcing in 2024: Expert insights & game-changing trends

    Tune into our top podcast episodes of 2024 so far covering AI, GLP-1, raising capital, career advice & much more.

  • July 12

    CPHI Podcast Series: The power of digital marketing in pharma 

    Raman, takes the hot seat on the CPHI podcast, and is interviewed on the power of digital marketing in life sciences by Lucy Chard.

  • Load more